Nasdaq · CIK 0001761918
ERAS Erasca, Inc.
Insider trading from SEC Form 4. Last filing Jun 26, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Signals
Open-market buys and sells at Erasca, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 22 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | Alexander W. Casdin director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| Jun 24, 2025 | Pratik S Multani director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| Jun 24, 2025 | Valerie Denise Harding Start director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| Jun 24, 2025 | Julie Hambleton director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| Jun 24, 2025 | Jean I Liu director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| Jun 24, 2025 | Michael David Varney director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| Jun 24, 2025 | James Arthur Bristol director | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| May 23, 2025 | Pratik S Multani director | GGift Common Stock | -6,200 | $0.00 | $0 | 166,666 | Jun 3, 2025 |
| May 23, 2025 | Pratik S Multani director | GGift Common Stockindirect: By Multani Family Trust U/A DTD 08/10/2006 | +6,200 | $0.00 | $0 | 6,200 | Jun 3, 2025 |
| Feb 13, 2025 | Ebun Garner General Counsel & Corp. Sec. | AGrant or award Stock option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 18, 2025 |
| Jun 14, 2024 | Ebun Garner General Counsel & Corp. Sec. | JOther Common Stock | +5,715 | $1.56 | $8,938 | 21,174 | Feb 5, 2025 |
| Jun 14, 2024 | David M. Chacko CFO and CBO | JOther Common Stock | +3,137 | $1.56 | $4,906 | 262,187 | Feb 5, 2025 |
| Feb 3, 2025 | Shannon Morris Chief Medical Officer | AGrant or award Stock option (right to buy)derivative | +780,000 | $0.00 | $0 | 780,000 | Feb 5, 2025 |
| Feb 3, 2025 | Jonathan E Lim Chairman & CEO | AGrant or award Stock option (right to buy)derivative | +2,500,000 | $0.00 | $0 | 2,500,000 | Feb 5, 2025 |
| Dec 13, 2024 | David M. Chacko CFO and CBO | JOther Common Stock | +12,324 | $1.56 | $19k | 262,187 | Feb 5, 2025 |
| Dec 13, 2024 | Ebun Garner General Counsel & Corp. Sec. | JOther Common Stock | +5,731 | $1.56 | $8,963 | 21,174 | Feb 5, 2025 |
| Feb 3, 2025 | Ebun Garner General Counsel & Corp. Sec. | AGrant or award Stock option (right to buy)derivative | +700,000 | $0.00 | $0 | 700,000 | Feb 5, 2025 |
| Feb 3, 2025 | David M. Chacko CFO and CBO | AGrant or award Stock option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Feb 5, 2025 |
| Jan 1, 2025 | James Arthur Bristol director | AGrant or award Stock Option (right to buy)derivative | +45,678 | $0.00 | $0 | 45,678 | Jan 2, 2025 |
| Jan 1, 2025 | Alexander W. Casdin director | AGrant or award Stock Option (right to buy)derivative | +28,877 | $0.00 | $0 | 28,877 | Jan 2, 2025 |
| Jan 1, 2025 | Valerie Denise Harding Start director | AGrant or award Stock Option (right to buy)derivative | +29,402 | $0.00 | $0 | 29,402 | Jan 2, 2025 |
| Jan 1, 2025 | Jean I Liu director | AGrant or award Stock Option (right to buy)derivative | +24,939 | $0.00 | $0 | 24,939 | Jan 2, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- James Arthur Bristoldirector
- Alexander W. Casdindirector
- David M. ChackoCFO and CBO
- Ebun GarnerGeneral Counsel & Corp. Sec.
- Julie Hambletondirector
- Jean I Liudirector
- Jonathan E LimChairman & CEO
- Shannon MorrisChief Medical Officer
- Pratik S Multaniofficer, director
- Valerie Denise Harding Startdirector
- Michael David Varneydirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.